IP Library Patent Application 18793396
Patent Application
App. No. 18/793,396

METHOD FOR NUCLEAR GENOME EDITING USING PLASTID SELECTABLE MARKERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/793,396
Abstract

The invention provides methods of using chloroplast-selectable markers to detect nuclear genome editing. The methods involve selecting a genetic modification that has occurred in a nuclear genome of a photosynthetic cell; transforming a photosynthetic cell with a ribonucleoprotein complex that effects a genetic modification in the genome in the nucleus of a photosynthetic cell; transforming the photosynthetic cell with a construct that effects an insertion of a selectable marker into the plastome of a plastid of the cell; selecting for photosynthetic cells having the selectable marker inserted into the plastome; and thereby selecting for the genetic modification to the genome in the nucleus of the photosynthetic cell.

Claims (30)

1 . A method of selecting for a genetic modification to a genome in the nucleus of a photosynthetic cell comprising:

transforming the photosynthetic cell with a ribonucleoprotein complex that effects a genetic modification in the genome in the nucleus of the photosoynthetic cell;

transforming the photosynthetic cell with a construct that effects an insertion of a selectable marker into the plastid of the photosynthetic cell;

selecting for photosynthetic cells comprising the selectable marker inserted into the plastid;

thereby selecting for the genetic modification to the genome in the nucleus of the photosynthetic cell.

2 . The method of claim 1 , wherein the insertion of the selectable marker into the plastid of the cell comprises inserting the selectable marker into the plastome.

3 . The method of claim 1 , wherein the plastid is a chloroplast.

4 . The method of claim 1 , further comprising sequencing at least a portion of the genome in the nucleus of the photosynthetic cell to confirm the genetic modification has been performed.

5 . The method of claim 1 , wherein selecting for photosynthetic cells comprises plating algal cells and selecting colonies comprising the insertion into the plastome.

6 . The method of claim 1 , wherein the selectable marker inserted into the plastome enables the photosynthetic cell to grow on an antibiotic.

7 . The method of claim 1 , wherein the antibiotic is erythromycin or spectinomycin.

8 . The method of claim 1 , wherein the selectable marker is glufosinate ammonium or the ptxD gene.

9 . The method of claim 1 , wherein the cells are plated onto selection agar plates.

10 . The method of claim 1 , wherein the ribonucleoprotein complex comprises a guide RNA targeted to a sequence on the genome in the nucleus of the photosynthetic cell and a Cas nuclease.

11 . The method of claim 1 , wherein the method does not comprise screening for a selectable marker comprised in the genome of the nucleus of the photosynthetic cell.

12 . The method of claim 1 , wherein the photosynthetic cell is an algal cell, and the algal cell is a Trebouxiophyte algal organism.

13 . The method of claim 12 , wherein the Trebouxiophyte algal organism is from the genus Oocystis.

14 . The method of claim 1 , wherein the construct that effects an insertion of a selectable marker into the plastid comprises RS-up and RS-down arms that recombine with homologous sequences in the plastome to thereby effect insertion; and the construct further comprises a selectable marker cassette in between the RS-up and RS-down arms.

15 . The method of claim 1 , any one of claims 1-14 wherein the construct is amplified by PCR prior to being transformed into the plastid.

16 . The method of claim 1 , wherein the construct further comprises a chloroplast promoter and chloroplast terminator that controls expression of the encoded selectable marker.

17 . The method of claim 16 , wherein the encoded selectable marker confers the ability to grow on media containing erythromycin, spectinomycin, or glufosinate ammonium.

18 . The method of claim 16 wherein the encoded selectable marker comprises the ptxD gene.

19 . The method of claim 1 , wherein the transformations are performed using biolistics.

20 . A composition comprising a ribonucleoprotein complex for editing a nuclear genome, and a construct comprising a selectable marker gene comprised in between two restriction site arms, each restriction site arm being homologous to corresponding sequences on a plastid genome.

21 . The composition of claim 20 , wherein the ribonucleoprotein complex comprises a guide RNA targeted to a site on the nuclear genome of a subject organism.

22 . The composition of claim 20 , wherein the ribonucleoprotein complex comprises Cas9.

23 . The composition of claim 21 , wherein the subject organism is a Chlorophyte organism.

24 . The composition of claim 23 wherein the Chlorophyte organism is a Trebouxiophyte alga.

25 . The composition of claim 20 , adsorbed to a microcarrier for biolistics.

26 . A kit comprising the composition claim 20 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2026
From: VIRIDOS, INC.
To: PHYKION INC.
Reel/Frame 073421/0601 →
SECURITY INTEREST Recorded Sep 13, 2024
From: VIRIDOS, INC.
To: BREAKTHROUGH ENERGY VENTURES II, L.P.
Reel/Frame 068589/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2024
From: VERRUTO, JOHN; STRIMLING, DANIEL
To: VIRIDOS, INC.
Reel/Frame 068167/0831 →